News

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...
Pfizer has stopped the development of its weight loss pill after a patient experienced a liver injury that was potentially ...
While melatonin supplements are popular, it's not always clear how much melatonin you should take. Here's what doctors ...
Below is a presentation of our financial results comparing FY 2024 to FY 2023, and are based on our results published in our Form 10-K filed with the SEC on April 15, 2025. Net income (loss) ...
If you’re struggling with sleep due to taking beta blockers, he says that taking between 2.5 to three milligrams is typical.
There is a misplaced argument about the use of artificial intelligence (AI) in healthcare that echoes the dystopian fears of Hollywood films like The Terminator ...
In April, researchers published findings in the journal "Nature" that explored how animal brains learn to associate certain ...
In another rebuke to federal regulatory overreach, the U.S. District Court for the Eastern District of Texas (“District Court ...
Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...
Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...
Grocery recalls are becoming increasingly more common. Compliance company Traceone reported in February 2025 that the total ...